Drugs / Bivalent Oral Poliomyelitis Vaccine (bOPV)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06137664 Comparator | Nov 2024 → Dec 2027 expected | poliomyelitis | PATH | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bivalent Oral Poliomyelitis Vaccine (bOPV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06137664 ↗ |
| Known as | bOPV | “Bivalent Oral Poliomyelitis Vaccine (bOPV)” NCT06137664 ↗ |
| Route | Oral | “Bivalent Oral Poliomyelitis Vaccine (bOPV)” NCT06137664 ↗ |